Article
Genetic Events Inhibiting Apoptosis in Diffuse Large B Cell Lymphoma
30 Apr 2021
Abstract excerpt
Diffuse large B cell lymphoma (DLBCL) is curable with chemoimmunotherapy in ~65% of patients. One of the hallmarks of the pathogenesis and resistance to therapy in DLBCL is inhibition of apoptosis, which allows malignant cells to survive and acquire further alterations. Inhibition of apoptosis can be the result of genetic events inhibiting the intrinsic or extrinsic apoptotic pathways, as well as their...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
